Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Early Phase 1
1(100.0%)
1Total
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03631680Terminated

The Role of Estrogen in Adipocyte Remodeling Following Surgical Menopause

Role: collaborator

NCT03582553Early Phase 1Completed

Safety and Pharmacokinetics of an Extract of Naringenin

Role: collaborator

NCT02675608Completed

Vaccine Efficacy in Diabetic and Elderly Patients

Role: collaborator

All 3 trials loaded